AMFV
4th Symposium,ISoP Latin American Chapter
Hervé Le Louët, FrancePresident CIOMS, Member of PRAC (EMA)Brian Edwards, UKISoP Chapters CoordinatorElki Sollenbring, Sweden UMC, Education and Consulting TeamAnthony Wong, Brazil Poison Control Centre (CEATOX)Liliana Vargas, MexicoNational Autonomous University of Mexico (UNAM)Luis Alesso, ArgentinaISoP Latin American Chapter PresidentRaquel Herrera Comoglio, ArgentinaISoP Latin American Chapter CoordinatorSten Olsson, Sweden ISoP President
SYMPOSIUM FACULTY
AMFV
FOURTH SYMPOSIUM,ISOP LATIN AMERICAN CHAPTERDECEMBER 5-6, 2017
AUDITORIUM HOSPITAL ANGELES ACOXPA430, CALZ ACOXPA 430, EX-HACIENDA COAPA,14308 CIUDAD DE MÉXICO, CDMX
ISoP, Latin American and Mexican Chapter welcome
Overview of the global pharmacovigilance situation and current trends
Developing a positive reporting culturePharmacovigilance in Latin America: Time to speak out
4th Symposium, ISoP Latin American ChapterAGENDA DEC 5IN COLLABORATION WITH THE ISOP MEXICAN CHAPTER
4th Symposium, ISoP Latin American ChapterAGENDA DEC 6IN COLLABORATION WITH THE ISOP MEXICAN CHAPTER
09:00-09:15
09:15-10:00
10:00-10:30
10:30-11:00
Time Section Talk Speaker Time Section Talk SpeakerOpening Sten Olsson
Luis AlessoEverardo Vázquez
Interactive Discussion Panel
Panel Chairman: Luis Alesso
09:00-10:30 Pharmacovigilancefrom the patientstandpoint
Carlos CastroBeatriz CapdevielleAlma RoblesRocío Alatorre Eden-WynterRosana Angélica RamirezSten Olsson
10:45-12:00 Pharmacovigilanceof Biotherapeuticmedicines
Present regulation in biologic therapies
13:00-14:45 Clinical Studies inPharmacovigilance
Brian Edwards
Medication errors: EU Regulatory initiatives on risk minimization
15:00-15:30
15:30-16:00
16:00-16:30
Pharmacovigilanceand Public Health
Hervé Le Louët
16:30-17:00 Closing Remarks Luis AlessoEverardo VázquezSten Olsson
Antibiotic resistance as a pharmacovigilance target
Carlos Amábile-Cuevas
Patient Safety in Public Health Programs
Sten Olsson
Naming, extrapolation, indication Abdiel Esquivel
Interchangeability and pharmacovigilance
Daniel Xibillé Friedman
Pharmacovigilance and Biologics Lucila Isabel Castro-Pastrana
The new Mexican regulation and its impact
11:30-13:00 Strategies forincreasing thequantity andquality ofspontaneousreporting
Rocío Alatorre Eden-Wynter
Pharmacovigilance: Impact of new regulation in México
Quality of the ADR reports – Sao Paulo, Brazil
Josue Bautista Arteaga
Adalton Ribeiro
Sten Olsson
Elki Sollenbring
Luis Alesso
Coffee Break
Coffee Break
Coffee Break
Lunch
CIOMS Perspective:Risk Management Plans
15:30-16:00
16:00-16:30
16:30-17:00
Risk managementPlans
Hervé Le Louët
RMP: Trials and tribulations…lessons to be learned
Brian Edwards
RMP: A collaborative perspective Gloria Giraldo
Coffee Break
Teaching Pharmacovigliance to Medical, Nursing and Pharmacy Students
14:00-15:10 TeachingPharmacovigilancein Universities
Anthony Wong
Carlos Calderon Ospina
Liliana Vargas
Marcelo Luis Ponte
Experience of Universidad del Rosario, Colombia
Learnings from National Autonomous University,Teaching Pharmacovigilance in Buenos Aires
Lunch Non insulin glucose-lowering agents and cardiovascular outcomes in Type 2 DM
Jorge Machado-AlbaExperiences from Colombia
Oscar Rosas-CarrascoElderly people safety
Raquel Herrera Comoglio